About Numais
Numais is a company based in Seoul (South Korea) founded in 2019. It operates as a B2B. Numais operates in a competitive market with competitors including AmacaThera, GelMEDIX and ENVISAGE, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Numais
Detailed funding history for Numais
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Numais
Investment portfolio details for Numais
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Numais
Detailed financials for Numais
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Numais Comparisons
Peer comparison for Numais
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Numais
Numais operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmacaThera, GelMEDIX and ENVISAGE, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Injectable hydrogel platform developed for therapeutic medical applications.
|
|
| Locked | Locked | Locked |
Hydrogel drug delivery technology for ophthalmic treatments is developed.
|
|
| Locked | Locked | Locked |
Biomedical solutions such as medical devices and hydrogels are provided.
|
Detailed competitors of Numais
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Numais
Complete news archive for Numais
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Numais
Numais was founded in 2019.
Numais is headquartered in Seoul, South Korea.
Numais develops innovative drug delivery systems for theragnostic treatments through providing healthcare solutions, advancing biotech innovations, drug delivery, and theragnostic treatments. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Numais's top competitors include AmacaThera, GelMEDIX and ENVISAGE.